#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Emphysema Spinal cord injury Neuronal ceroid lipofuscinosis Rhabdomyosarcoma recurrent Meningococcal immunisation Encephalitis autoimmune Restless legs syndrome Primary hyperoxaluria Anaplastic thyroid cancer Alagille syndrome Retinopathy of prematurity Liver abscess Thyroid cancer metastatic Pulmonary alveolar haemorrhage Liposarcoma More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Treatment Glycogen storage disease type II – Life with Disease Haemophagocytic lymphohistiocytosis – Basic Information Alexander disease – Diagnostics Systemic sclerosis pulmonary – Trials in Disease Basal cell naevus syndrome – Diagnostics Osteosarcoma recurrent – Trials in Disease Pleomorphic leiomyosarcoma Adrenocortical carcinoma – Life with Disease Turner’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betamethasone Sodium Phosphate FERUMOXTRAN-10 Vorasidenib Gskvx000000008866 Polydextrose Sodium Phosphate Olanzapine Liraglutide MAPLIRPACEPT Temsirolimus Nedosiran Rituximab Prasugrel STREPTOCOCCUS PYOGENES Azd5492 Salmeterol Xinafoate Selgantolimod Bay 3283142 Ro7589655 Tas3351 More therapies…

    Learn about Your Condition

    Cholecystitis acute Haemoglobinuria Hypopituitarism Papulopustular rosacea Oedema peripheral Breast angiosarcoma Ulcerative keratitis Apathy Essential thrombocythaemia Lumbosacral radiculopathy Peritoneal sarcoma Agitation Frostbite Solitary fibrous tumour Haemoptysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    Investigated Drugs:
    • Ampicillin Sodium
    • POLYMYXIN B SULFATE
    • Rifabutin
    Croatia Greece

  • Metronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Clarithromycin
    • Esomeprazole
    • Tetracycline Hydrochloride
    Greece

  • Comparing pivmecillinam and gentamicin with standard treatments for hospitalized adults with complicated urinary tract infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Betamethasone Valerate
    • Gentamicin Sulfate
    • Ampicillin Sodium
    Denmark

  • A study to compare weekly or event-based use of doxycycline to prevent sexually transmitted infections in men who have sex with men and transgender women using HIV prevention medication.

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Doxycycline
    Belgium

  • Comparing the effectiveness of 7 days versus 14 days of ciprofloxacin or ceftriaxone for treating kidney infection in kidney transplant recipients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis
    Investigated Drugs:
    • Ciprofloxacin
    • Ciprofloxacin Hydrochloride
    • Ceftriaxone
    Spain

  • Study of chlorhexidine, metronidazole, and FB301 for the treatment of women with bacterial vaginosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial vaginosis
    Investigated Drugs:
    • Chlorhexidine Gluconate
    • Metronidazole
    Germany
1 2 3 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!